GSA Capital Partners’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-61,652
| Closed | -$347K | – | 1976 |
|
|
2021
Q4 | $347K | Buy |
61,652
+57,627
| +1,432% | +$324K | 0.04% | 843 |
|
|
2021
Q3 | $45K | Sell |
4,025
-16,759
| -81% | -$187K | ﹤0.01% | 1350 |
|
|
2021
Q2 | $352K | Buy |
20,784
+3,098
| +18% | +$52.5K | 0.04% | 842 |
|
|
2021
Q1 | $464K | Buy |
17,686
+666
| +4% | +$17.5K | 0.08% | 394 |
|
|
2020
Q4 | $615K | Buy |
17,020
+12,576
| +283% | +$454K | 0.1% | 306 |
|
|
2020
Q3 | $157K | Buy |
+4,444
| New | +$157K | 0.03% | 1061 |
|